Conversely, data on P2Y12 inhibitor monotherapy showed more consistent results, with all trials reporting no significant interaction between the benefit of P2Y12 inhibitor monotherapy and diabetes mellitus [60,61,116,117]. Here, P2RY12 is linked to diabetes mellitus.